News

Following the acquisition, Vicebio's non-mRNA candidate vaccine for treating respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) will be added to Sanofi's range.
A strategic milestone for the capital to strengthen global health security, ensure equitable vaccine access and build resilient supply chains ...
ABU DHABI, 8th July, 2025 (WAM ... the Innovative Genomics Institute, Sanofi, Boehringer Ingelheim, Abbott, Aetna ...
The Emirates Drug Establishment (EDE) has granted official approval for Rilzabrutinib, the first oral Bruton’s tyrosine ...
Sanofi's antibody riliprubart has received orphan drug designation (ODD) from Japan's Ministry of Health, Labour and Welfare (MHLW) for its potential to treat chronic inflammatory demyelinating ...
Located in KEZAD and operated by Rafed, a subsidiary of PureHealth, the hub was developed in collaboration with the DoH, Abu ...
From majestic mountains to stunning architecture to world-class art, here’s our insider’s guide to the best things to do in ...
Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate of Abu Dhabi, has announced the operational launch of the region’s vaccine distribution ...
Abu Dhabi's vaccine distribution hub, developed in partnership with stakeholders including Etihad Cargo, has begun operations ...
Simmons & Simmons is planning a return to Abu Dhabi to capitalise on the city’s growing asset management and tech sectors, ...
White sand beaches, incredible museums, and a diversity of global cuisines await in the UAE’s action-packed capital. Here’s our guide to where to stay, what to eat, and what to know before you visit.
Abu Dhabi National Oil Company said on Wednesday it plans to transfer its 24.9% shareholding in Austria's OMV AG to its XRG ...